Cargando…

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis

BACKGROUND: Serological assays are being used to monitor antibody responses in individuals who had SARS-CoV-2 infection and those who received a COVID-19 vaccine. We aimed to determine whether such assays can predict neutralising antibody titres as antibody levels wane and viral variants emerge. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muecksch, Frauke, Wise, Helen, Templeton, Kate, Batchelor, Becky, Squires, Maria, McCance, Kirsty, Jarvis, Lisa, Malloy, Kristen, Furrie, Elizabeth, Richardson, Claire, MacGuire, Jacqueline, Godber, Ian, Burns, Alana, Mavin, Sally, Zhang, Fengwen, Schmidt, Fabian, Bieniasz, Paul D, Jenks, Sara, Hatziioannou, Theodora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141682/ https://www.ncbi.nlm.nih.gov/pubmed/35636436 http://dx.doi.org/10.1016/S2666-5247(22)00090-8

Ejemplares similares

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity
por: Muecksch, Frauke, et al.
Publicado: (2021)

Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting
por: McCance, Kirsty, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland
por: McDonald, Lindsay, et al.
Publicado: (2021)

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
por: Muecksch, Frauke, et al.
Publicado: (2020)

Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
por: Muecksch, Frauke, et al.
Publicado: (2020)

Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection
por: Poston, Daniel, et al.
Publicado: (2020)

Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
por: Poston, Daniel, et al.
Publicado: (2020)

SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity
por: Zhang, Fengwen, et al.
Publicado: (2023)

Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
por: Yang, Leerang, et al.
Publicado: (2022)

Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain
por: Yang, Leerang, et al.
Publicado: (2023)

SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
por: Zhang, Fengwen, et al.
Publicado: (2011)

A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques.
por: Baisa, Gary, et al.
Publicado: (2021)

“A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.”
por: Baisa, Gary, et al.
Publicado: (2020)

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients
por: Luchsinger, Larry L., et al.
Publicado: (2020)

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
por: Luchsinger, Larry L., et al.
Publicado: (2020)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Plasma neutralization properties of the SARS-CoV-2 Omicron variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
por: Gaebler, Christian, et al.
Publicado: (2022)

National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic
por: Palmateer, N.E., et al.
Publicado: (2021)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2023)

The Techniques: middleware developers' golden rules
por: Gavin McCance
Publicado: (2008)

Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo
por: Schäfer, Alexandra, et al.
Publicado: (2020)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

Endocrine Autoimmunity and Associated Conditions
por: McCance, David R
Publicado: (1999)

Membership Matters
por: McCance, David R.
Publicado: (1998)

The Role of the Developing Kidney in the Maintenance of Internal Stability
por: McCance, R. A.
Publicado: (1972)

DNA Cloning 3: Complex genomes: Edited by D.M. Glover and B.D. Hames. Oxford Science, Oxford. ISBN 0-19-963483-1; 0-19-963482-3. Price: £50 (hardback); £25 (paperback)
por: McCance, Dennis J.
Publicado: (1996)

Pauli Biographical Collection: Letter
por: MacGuire, W
Publicado: (2004)

Pauli Biographical Collection: Letter
por: MacGuire, W
Publicado: (2004)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Assisted Evolution Enables HIV-1 to Overcome a High TRIM5α-Imposed Genetic Barrier to Rhesus Macaque Tropism
por: Soll, Steven J., et al.
Publicado: (2013)

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137
por: Zhang, Fengwen, et al.
Publicado: (2020)

Reducing Health Inequalities in Aging Through Policy Frameworks and Interventions
por: MacGuire, Frances A. S.
Publicado: (2020)

Abstract of Paper on Abortion
por: MacGuire, R. J.
Publicado: (1897)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
por: Cho, Alice, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_af8roivp3s3gndo161krbja0e7